Thromb Haemost 2001; 85(04): 634-638
DOI: 10.1055/s-0037-1615645
Review Articles
Schattauer GmbH

Standardisation of Factor VIII and von Willebrand Factor in Plasma: Calibration of the 4th International Standard (97/586)

Anthony R. Hubbard
1   Division of Haematology and Informatics Laboratory, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, UK
,
Peter Rigsby
2   Informatics Laboratory, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, UK
,
Trevor W. Barrowcliffe
1   Division of Haematology and Informatics Laboratory, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, UK
› Author Affiliations
Further Information

Publication History

Received 09 October 2000

Accepted after revision 30 November 2000

Publication Date:
08 December 2017 (online)

Summary

The 4th International Standard (IS) Factor VIII/von Willebrand Factor (FVIII/VWF) plasma was calibrated in 25 laboratories by assay against the 3rd IS plasma and fresh normal plasma pools. Five parameters were measured, FVIII:coagulant activity (FVIII:C), FVIII:Antigen (FVIII:Ag), VWF:Antigen (VWF:Ag), VWF:Ristocetin Cofactor (VWF:RCof), and a new parameter, VWF:collagen binding (VWF:CB). Mean potency estimates for the 4th IS, calculated relative to the 3rd IS, were significantly greater than the mean estimates calculated relative to the fresh normal pools by 15, 14 and 20% respectively for FVIII:C, VWF:Ag and VWF:RCof. These results indicate a drift in the International Unit away from the fresh plasma unit. Partial rectification of this drift was achieved by assigning the mean of the estimates calculated relative to the 3rd IS and the fresh plasma pools, i.e. FVIII:C 0.57 IU/ampoule, VWF:Ag 0.79 IU/ampoule and VWF:RCof 0.73 IU/ampoule. This represents a shift in the IU between the 3rd and 4th IS of 7.5% for FVIII:C, 7% for VWF:Ag and 10% for VWF:RCof. Mean estimates of FVIII:Ag relative to the 3rd IS and the fresh normal pools agreed to give an assigned value of 0.89 IU/ampoule. Excessive inter-laboratory variability and a low number of estimates (n = 6) precluded the assignment of a potency for VWF:CB. The 4th IS Factor VIII/VWF plasma (97/586) was established in October 1998.

 
  • References

  • 1 Barrowcliffe TW, Thomas DP. The provision of standards for blood coagulation factors. Recent Advances in Blood Coagulation. Poller L. ed. Churchill Livingstone; 1985. 4 251-66.
  • 2 Barrowcliffe TW, Tydeman MS, Kirkwood TBL, Thomas DP. Standardization of Factor VIII–III. Establishment of a stable reference plasma for Factor VIII-related activities. Thromb Haemost 1983; 50: 690-6.
  • 3 Heath AB, Barrowcliffe TW. Standardisation of Factor VIII–V. Calibration of the 2nd International Standard for Factor VIII and von Willebrand Factor activities in plasma. Thromb Haemost 1992; 68: 155-9.
  • 4 Campbell PJ. International biological standards and reference preparations. 1. Preparation and presentation of materials to serve as standards and reference preparations. J Biol Standardisation 1974; 2: 249-67.
  • 5 Finney D. Statistical Method in Biological Assay. Charles Griffin; London: 1978
  • 6 Kirkwood TBL. Geometric means and measures of dispersion. Biometrics 1979; 35: 908-9.
  • 7 Kirkwood TBL, Tydeman MS. Design and analysis of accelerated degradation tests for the stability of biological standards II. A flexible computer program for data analysis. J Biol Standardisation 1984; 12: 207-14.
  • 8 Rotblat F, Tuddenham EGD. Immunologic studies of Factor VIII coagulant activity 1. Assays based on a hemophilic and an acquired antibody to VIII:C. Thrombosis Research 1981; 21: 431-45.
  • 9 Smith JF, Ness PM, Moroff G, Luban NLC. Retention of coagulation factors in plasma frozen after extended holding at 1-6° C. Vox Sanguinis 2000; 78: 28-30.
  • 10 Brown JE, Bosak JO. An ELISA test for the binding of von Willebrand antigen to collagen. Thrombosis Research 1986; 43: 303-11.
  • 11 Favaloro EJ. Collagen binding assay for von Willebrand Factor (VWF:CBA): Detection of von Willebrands Disease (VWD), and discrimination of VWD subtypes, depends on collagen source. Thromb Haemost 2000; 83: 127-35.